Handok Inc. | Mutual Funds
Mutual Funds that own Handok Inc.
DFA Emerging Markets Small Cap Series
46,806
0.34%
0
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
38,996
0.28%
2,575
0%
04/30/2018
Mirae Asset TIGER Health Care ETF
14,696
0.11%
4,715
0.25%
04/30/2018
iShares III Plc - MSCI Emerging Markets Small Cap
4,413
0.03%
0
0.03%
09/05/2018
CREF Stock Account
3,428
0.03%
0
0%
03/31/2018
2,979
0.02%
1,920
0.04%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
2,706
0.02%
0
0.01%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
2,003
0.02%
718
0%
12/31/2017
DFA International Core Equity Fund
1,285
0.01%
1,285
0%
12/31/2017
John Hancock II - Emerging Markets Fund
942
0.01%
0
0%
04/30/2018
| Address |
132 Teheran-ro
Seoul SL 06235
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.handok.co.kr |
| Updated |
07/08/2019 |
| Handok, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Medicine, Medical Device, Healthcare Product, Rental, and Gene Analysis. The Medicine business offers ETC and OTC medicines. |
